Select a language
The European Commission plans to introduce a simplify the procedure for carrying out pharmaceutical tests on humans. The text, which will be debated in parliament in June, will dispense with the requirement for independent ethical committees to be involved in the authorisation of tests.
In future, a single member state (and more importantly, one selected by the healthcare industry) will evaluate the risks involved in trials for a particular product, and its decision will apply for all other member states. Doctors have pointed out that states with a record for imposing higher standards will be systematically circumvented, and that the constraints on human testing will be less rigorous than those that apply for animal testing.
A conversation with investigative reporters Stefano Valentino and Giorgio Michalopoulos, who have dissected the dark underbelly of green finance for Voxeurop and won several awards for their work.
Go to the event >